Needham Downgrades Momentive Glb to Hold
Needham analyst Ryan MacDonald downgrades Momentive Glb (NASDAQ:MNTV) from Buy to Hold.
HSBC Maintains Buy on Lufax Holding, Lowers Price Target to $3
HSBC analyst Carson Lo maintains Lufax Holding (NYSE:LU) with a Buy and lowers the price target from $4 to $3.
HC Wainwright & Co. Reiterates Buy on Oncternal Therapeutics, Maintains $7 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and maintains $7 price target.
HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $26
HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price target from $27 to $26.
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $15 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $15 price target.
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
B of A Securities Upgrades Portland Gen Electric to Buy, Announces $52 Price Target
B of A Securities analyst Julien Dumoulin-Smith upgrades Portland Gen Electric (NYSE:POR) from Neutral to Buy and announces $52 price target.
Jefferies Initiates Coverage On Academy Sports with Buy Rating, Announces Price Target of $73
Jefferies analyst Anna Glaessgen initiates coverage on Academy Sports (NASDAQ:ASO) with a Buy rating and announces Price Target of $73.
JP Morgan Upgrades Vermilion Energy to Overweight
JP Morgan analyst Arun Jayaram upgrades Vermilion Energy (NYSE:VET) from Neutral to Overweight.
JP Morgan Downgrades Ovintiv to Neutral, Lowers Price Target to $53
JP Morgan analyst Arun Jayaram downgrades Ovintiv (NYSE:OVV) from Overweight to Neutral and lowers the price target from $59 to $53.